Insulin aspart, recombinant Subcutaneous and Merrem IV
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Merrem IV and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: meropenem
Brand name: Merrem, Merrem Novaplus
Synonyms: Merrem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Merthiolate
- Insulin aspart, recombinant Subcutaneous-Meruvax II
- Insulin aspart, recombinant Subcutaneous-Mesalamine
- Insulin aspart, recombinant Subcutaneous-Mesalamine Controlled-Release Capsules
- Insulin aspart, recombinant Subcutaneous-Mesalamine Delayed Release Tablets
- Insulin aspart, recombinant Subcutaneous-Mesalamine Long-Acting Capsules (Apriso)
- Merrem IV-Insulin degludec
- Merrem IV-Insulin Degludec (U-100) Prefilled Pens
- Merrem IV-Insulin Degludec (U-100) Vials
- Merrem IV-Insulin Degludec (U-200) Prefilled Pens
- Merrem IV-Insulin degludec and liraglutide
- Merrem IV-Insulin degludec and liraglutide Subcutaneous